Public Offering	6 Months Ended
Jun. 30, 2024
Public Offering
Public Offering	Note 4—Public Offering On October 25, 2021, the Company closed on the Public Offering and sale, including the underwriters’ partial exercise of their over-allotment option, of 20,000,000 Units. Each Unit consists of one Class A Ordinary Share and one-half of one Public Warrant. Each whole Public Warrant offered in the Public Offering is exercisable to purchase one Class A Ordinary Share. See Note 7. The Company granted the underwriters a 45-day option to purchase up to 2,625,000 additional Units to cover any over-allotments, at the Public Offering price less the underwriting discounts and commissions. At the closing of the Public Offering on October 25, 2021, the underwriters’ exercised 2,500,000 Units of such over-allotment option. The warrants that were issued in connection with 2,500,000 over-allotment units exercised are identical to the Public Warrants and have no net cash settlement provisions. As discussed further in Note 8, after the closing of the Public Offering on October 25, 2021, 31,250 of the outstanding Class B Ordinary Shares remained forfeitable and in December 2021 those 31,250 ordinary shares were surrendered and retired. The Company paid an underwriting discount of 2.0% of the per Unit price, $4,000,000, to the underwriters at the closing of the Public Offering and was obligated to pay a deferred underwriting fee of 3.5% of the per Unit price, $7,000,000, upon the completion of the Company’s initial business combination. On October 3, 2022, one of the underwriters in the Company’s October 25, 2021 Public Offering agreed to forfeit their 47.5% interest in the deferred underwriting compensation of $7,000,000. As such $3,325,000 was reduced from the deferred underwriting compensation liability and from Class A Ordinary Shares subject to redemption, reducing the amount of this liability from $7,000,000 to $3,675,000 at December 31, 2023. In April 2024, the remaining underwriter in the Company’s October 25, 2021 Public Offering agreed to forfeit their remaining 52.5% interest in the deferred underwriting compensation of $7,000,000. As such $3,725,000 was reduced from the deferred underwriting compensation liability and from Class A Ordinary Shares subject to redemption, reducing the amount of this liability from $3,675,000 to $0 as of June 30, 2024. As of June 30, 2024 and December 31, 2023, the amount outstanding in the Trust Account was approximately $23,626,000 and $22,890,000, respectively.

Public Offering

6 Months Ended

Jun. 30, 2024

Note 4—Public Offering

On October 25, 2021, the Company closed on the Public Offering and sale, including the underwriters’ partial exercise of their over-allotment option, of 20,000,000 Units. Each Unit consists of one Class A Ordinary Share and one-half of one Public Warrant. Each whole Public Warrant offered in the Public Offering is exercisable to purchase one Class A Ordinary Share. See Note 7.

The Company granted the underwriters a 45-day option to purchase up to 2,625,000 additional Units to cover any over-allotments, at the Public Offering price less the underwriting discounts and commissions. At the closing of the Public Offering on October 25, 2021, the underwriters’ exercised 2,500,000 Units of such over-allotment option. The warrants that were issued in connection with 2,500,000 over-allotment units exercised are identical to the Public Warrants and have no net cash settlement provisions. As discussed further in Note 8, after the closing of the Public Offering on October 25, 2021, 31,250 of the outstanding Class B Ordinary Shares remained forfeitable and in December 2021 those 31,250 ordinary shares were surrendered and retired.

The Company paid an underwriting discount of 2.0% of the per Unit price, $4,000,000, to the underwriters at the closing of the Public Offering and was obligated to pay a deferred underwriting fee of 3.5% of the per Unit price, $7,000,000, upon the completion of the Company’s initial business combination.

On October 3, 2022, one of the underwriters in the Company’s October 25, 2021 Public Offering agreed to forfeit their 47.5% interest in the deferred underwriting compensation of $7,000,000. As such $3,325,000 was reduced from the deferred underwriting compensation liability and from Class A Ordinary Shares subject to redemption, reducing the amount of this liability from $7,000,000 to $3,675,000 at December 31, 2023. In April 2024, the remaining underwriter in the Company’s October 25, 2021 Public Offering agreed to forfeit their remaining 52.5% interest in the deferred underwriting compensation of $7,000,000. As such $3,725,000 was reduced from the deferred underwriting compensation liability and from Class A Ordinary Shares subject to redemption, reducing the amount of this liability from $3,675,000 to $0 as of June 30, 2024.

As of June 30, 2024 and December 31, 2023, the amount outstanding in the Trust Account was approximately $23,626,000 and $22,890,000, respectively.